Previous Close | 493.00 |
Open | 498.00 |
Bid | 496.00 x 10000 |
Ask | 499.00 x 10000 |
Day's Range | 498.00 - 498.00 |
52 Week Range | 319.00 - 498.00 |
Volume | |
Avg. Volume | 8 |
Market Cap | 66.085B |
Beta (5Y Monthly) | 0.44 |
PE Ratio (TTM) | 24.40 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 2.29 (0.46%) |
Ex-Dividend Date | Feb 29, 2024 |
1y Target Est | N/A |
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
Pharmacy chain Rite Aid has reached a settlement with its lenders, the U.S. Department of Justice, and drug supplier McKesson Corp, clearing a path for Rite Aid to complete its bankruptcy case by late April, a company lawyer said Tuesday. "We have reached an agreement on all key points with all key economic stakeholders," Rite Aid attorney Aparna Yenamandra said at a bankruptcy court hearing in Trenton, New Jersey. Yenamandra did not provide details about the settlement, saying that some issues needed to be worked out before it can be presented in court.
(Bloomberg) -- Rite Aid Corp. is nearing a deal with key bondholders and other creditor groups that will allow the pharmacy chain to avoid a liquidation, according to people with knowledge of the matter. Most Read from BloombergTrump’s Net Worth Hits $6.5 Billion, Making Him One of World’s 500 Richest PeopleTrump Vows to Pay Fraud Trial Bond Cut by 68% to $175 MillionBiden Gains Ground Against Trump in Six Key States, Poll ShowsVital Baltimore Bridge Collapses After Being Struck by ShipAfter Exp